Dr. Eric Daniel Nudleman, MD, PhD

Dr. Nudleman practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Nudleman's NPI, 1154582575, was assigned on June 18, 2008. Dr. Nudleman graduated from Albert Einstein College of Medicine in 2008. Dr. Nudleman holds California license A131592.

Dr. Nudleman's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Nudleman's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Nudleman is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Nudleman to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nudleman practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Nudleman's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Nudleman is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Nudleman's licenses on file in 3 states: California, Michigan and Missouri.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, dry eye, glaucoma, hypertensive retinopathy, retinal detachment and retinal occlusion among the conditions Dr. Nudleman treats.

CMS data shows 13,444 Medicare services from Dr. Nudleman across 10 procedure codes in 2024, for 896 Medicare patients. Medicare paid $683,184 for them. Every service was in an office.

CMS counts 896 Medicare patients who saw Dr. Nudleman in 2024. The largest group is 75 to 84, with 377 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Nudleman's median patient age at 64, with 52% women.

In 2024, Dr. Nudleman wrote 73 Medicare Part D claims for 33 patients. 51% of them were for generic drugs. CMS names the drug for 52 of them, across 3 drugs with 11 or more claims each, at $1,233 in total drug cost. In 2023, CMS named 61 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Nudleman for performance year 2024, reported as part of a group. Dr. Nudleman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 80 papers to Dr. Nudleman, published from 2011 to 2024. 2019 was the busiest year, with 8. The most frequent topics are Fluorescein Angiography, Tomography, Optical Coherence and Visual Acuity. Dr. Nudleman has published most often in Retina. Dr. Nudleman's most frequent co-authors are Antonio Capone, MD, William R. Freeman, MD and John Peter Campbell, MD, MPH.

Dmand AI links Dr. Nudleman to 2 clinical trials. Conditions studied include Cystinosis and Lysosomal Storage Diseases. Open Payments lists research payments to Dr. Nudleman that name 1 trial.

CMS Open Payments shows 281 general payments to Dr. Nudleman from 19 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 64% of the total. Alcon Laboratories Inc paid the most, $161,239. It also lists 27 research payments totaling $22,976 from 2016 to 2025, naming 1 clinical trial.

Dr. Nudleman graduated from Albert Einstein College of Medicine in 2008.

Dr. Nudleman is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.